I'm Josh Jorgenson. I build ClearLeaf on my own — no company, no team, no investors — the same way I build its older sibling, Norvayo, a tracking and quit-support app for nicotine pouches.
One engine, a second habit
Norvayo came first, out of my own several-year effort to quit nicotine pouches. Building it taught me something I didn't expect: almost none of what actually helps — an adaptive daily plan, a slip that resets your streak without erasing your progress, private accountability instead of a public feed — is specific to nicotine. It's specific to the shape of quitting something, whatever the something is.
Cannabis was the next obvious habit to build for, and the request I heard most often once Norvayo was out. So ClearLeaf takes the same core — the taper logic, the craving tools, the Circles accountability model, the guided day-by-day program — and rebuilds the parts that genuinely differ: what you're tracking (a session, not a pouch), how you talk about it, and the content, which is written specifically about cannabis withdrawal and cravings rather than nicotine's.
What's actually different from Norvayo
- Sessions, not pouches. Flower, vape, edible, concentrate, or pre-roll — logged the way you actually use it, not forced into a nicotine-shaped unit.
- No fabricated numbers. A reliable per-session THC dose isn't something anyone can estimate honestly, so ClearLeaf doesn't show one. It tracks sessions avoided and money saved from your own numbers — nothing invented.
- Content written for cannabis, specifically. Withdrawal timing, the mental shift in week two, sleep and vivid dreams, weed and anxiety — these aren't nicotine articles with the nouns swapped. They're written for what actually happens when you cut back or stop using cannabis.
- Cold turkey, taper, cut back, or a tolerance break. Quitting outright isn't everyone's goal with cannabis the way it usually is with nicotine — ClearLeaf treats a planned tolerance break as a first-class option, not an afterthought.
What carried over unchanged
The things that made Norvayo worth building in the first place aren't nicotine-specific, so they came straight across: a slip that resets your streak but never your earned badges or lifetime totals, Autopilot pacing that adapts to your real routine instead of a fixed schedule, and Circles — private accountability with one partner or a small group, never a public feed.
What I'm not
I'm not a doctor, a therapist, or a counselor, and I don't have medical or clinical training in substance use. Nothing on this site or in the app is medical advice, and I try to write from the same place Norvayo does — plain, honest, and sourced — rather than claiming authority I don't have. Where the app or its content library states facts about cannabis or withdrawal, they're linked to sources that do have the expertise, such as NIDA and published research on cannabis withdrawal syndrome.
If you want support from someone qualified, a doctor or a licensed counselor is a better starting point than an app, mine included.
How the app makes money, plainly
ClearLeaf is free to use, and the parts that help you get through a craving are free permanently — logging, the coping tools, the guided program, streaks and badges, a full taper plan, one accountability partner, and exporting your own data. ClearLeaf Premium adds pattern analysis, paced daily windows via Autopilot, longer trend charts, and small-group Circles.
There are no ads and no analytics SDKs in the app, and your data is never sold or shared with third parties. That's not a positioning statement — it's in the privacy policy and the Play Store data safety declarations, and you can hold me to it.
Where it is right now
ClearLeaf is newer than Norvayo and is Android-only today, with an iOS version planned the same way Norvayo's is. It's early — I'd rather say that plainly than let the site imply otherwise.
Getting in touch
If something here is wrong, or the app did something confusing, I'd genuinely like to know: support@clearleaf.us. It goes to me.